Open AccessEfficacy and safety of epirubicin applied in transcatheter arterial chemoembolization for hepatocellular carcinoma
Author(s) -
Zhang Bai,
Yuan Qin,
Guangyu Zhu,
Guofeng Zhao,
Gang Deng,
Jun Guo,
Shi-Cheng He
Publication year - 2018
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/jcrt.jcrt_1261_16
Subject(s) - medicine , jadad scale , epirubicin , hepatocellular carcinoma , confidence interval , publication bias , relative risk , meta analysis , gastroenterology , transcatheter arterial chemoembolization , oncology , chemotherapy , cyclophosphamide , cochrane library
This study was aimed to evaluate the efficacy and safety of epirubicin applied in transcatheter arterial chemoembolization (TACE) for the treatment of hepatocellular carcinoma (HCC).